GSK extends strategic collaboration with Aspen
GSK to acquire 16% shareholding in Aspen in exchange for transfer of specialist products and manufacturing facility in Bad Oldesloe, DE.
Read the full articleYou might also wanna read
GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to
cnbc.com·1mo ago
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
Deal would rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
ft.trib.al·1mo ago
GSK acquires cancer drug developer Nuvalent in $10.6 billion deal
Biotech firm is developing small molecules for lung cancers
cen.acs.org·29d ago
GSK agrees $10 billion deal for Nuvalent cancer drugs
Deal includes two late-stage molecules to augment GSK’s renewed cancer therapy pipeline
So entgeht SAP einer EU-Kartellstrafe
Europas größter Softwarekonzern entgeht einer möglichen Milliardenbuße, weil er den Markt für die Wartung seiner ERP-Software öffnet. Für Un
Marktbericht: Tech-Ausverkauf belastet Börse
Kräftige Kursverluste von KI-Aktien drücken den DAX. Samsung-Zahlen enttäuschen. Anleger scheuen trotz guter Konjunkturzahlen das Risiko.
Comments
Sign in to join the conversation.
No comments yet. Be the first.